In order to determine the frequency of extended use of non-steroidal anti-inflammatory drugs (NSAID) in Colombian patients with high cardiovascular risk (HCVR), a retrospective study was developed which identified HCVR patients who used NSAID for over five continuous months from January 2011 and March 2013. Patients chronically receiving nitrates, digitalis and clopidogrel and acetylsalicylic acid (ASA), known as HCVR, were identified. An analysis of the frequencies of use based on the co-medication received was performed. Concomitant use of NSAID was found in 0,35% of consumers of nitrates (average time: 9,5 ± 4,4 months), in 0,36% of consumers of clopidogrel and ASA (average time: 9,3 ± 3,4 months), and in 0,4% of consumers of digitalis (10,2 ± 4,6 months). It is concluded that there is a low proportion of chronic use of NSAID in high-risk cardiovascular patients. Key words: Cardiovascular diseases; Anti-Inflammatory agents, non-steroidal; Pharmacoepidemiology; Pharmacovigilance; Colombia (source: MeSH NLM). (English) [ABSTRACT FROM AUTHOR]
CITATION STYLE
Machado-Alba, J. E., Alzate-Carvajal, V., & Echeverri-Cataño, L. (2014). Estudio farmacoepidemiológico acerca de uso de antiinflamatorios no esteroideos en pacientes de alto riesgo cardiovascular. Revista Peruana de Medicina Experimental y Salud Pública, 30(4). https://doi.org/10.17843/rpmesp.2013.304.243
Mendeley helps you to discover research relevant for your work.